Qualimedis and Verso Healthcare are facilitating access to ViewRay®’s MRIdian™ Linac system, the world’s first and only MRI-guided system for adaptive radiotherapy, with real-time monitoring synchronised with radiation delivery. It is a major example of the challenges of introducing and rapidly deploying innovations in radiotherapy.
Qualimedis, the distributor of this technology in France, and Verso Healthcare, the European expert in financial engineering and medical technology, have joined forces to offer establishments a unique turnkey solution that is perfectly suited to this technology, its implementation and the financial balance linked to the centre’s growing activity. This turnkey offer is based on the deployment, optimisation, innovation and availability of the ViewRay® MRIdian™ Linac system from a security, economic, technical and regulatory perspective. No more questions to ask and no more risk of obsolescence by ensuring availability, economic efficiency and security at the centre.
This 360° offer has also attracted the national purchasing group UniHA, which recently adopted it as part of a 4-year public contract, thus also allowing public health establishments to have immediate access to it, with total exemption from advertising and competition obligations.